ROFFEEI, Siti Norsyuhada, MOHAMED, Zahurin, REYNOLDS, Gavin, SAID, Mas Ayu, HATIM, Ahmad, MOHAMED, Elsa Haniffah Mejia, AIDA, Syarinaz Ahmad and ZAINAL, Nor Zuraida (2014). Association of FTO,LEPR and MTHFR gene polymorphisms with metabolic syndrome in schizophrenia patients receiving antipsychotics. Pharmacogenomics, 15 (4), 477-485.Full text not available from this repository.
Aim: The occurrence of metabolic syndrome (MS) in schizophrenia patients receiving long-term antipsychotics (APs) contributes to their high mortality rate. We aimed to determine whether genetic polymorphisms of identified candidate genes are associated with MS in our study population. Materials & methods: We recruited 206 schizophrenia patients receiving AP treatment for at least a year. Cross-sectional measurements of weight, height, blood pressure, waist and hip circumference, and other lipid profiles were recorded. Patient DNA was genotyped for 16 candidate gene polymorphisms. Results: Of these patients, 59.7% were found to have MS while 40.3% did not. All metabolic parameters were significantly different between the two groups. Only three of the 16 polymorphisms studied showed significant association with MS; rs9939609 of the FTO gene confers risk for MS (odds ratio [OR]: 1.73, 95% CI: 1.07-2.78, p = 0.026), while rs1137101 of the LEPR gene (OR: 0.47, 95% CI: 0.28-0.80, p = 0.005) and rs1801133 of the MTHFR gene (OR: 0.59, 95% CI: 0.35-0.99, p = 0.049) are protective against MS. Conclusion: Polymorphisms of the FTO, LEPR and MTHFR genes may play a role in MS in Malaysian schizophrenia patients receiving long-term treatment with APs.
|Research Institute, Centre or Group:||Biomolecular Sciences Research Centre|
|Depositing User:||Ann Betterton|
|Date Deposited:||16 Dec 2014 16:00|
|Last Modified:||16 Dec 2014 16:00|
Actions (login required)
Downloads per month over past year